Unresolved disorder model. using A ATOM 277 N AGLY 36 9.228 53.359 -4.423 0.67 61.77 N Unresolved disorder model. using A ATOM 278 N BGLY 36 9.358 53.357 -4.482 0.33 59.22 N Unresolved disorder model. using A ATOM 279 CA AGLY 36 8.495 53.901 -5.560 0.67 63.25 C Unresolved disorder model. using A ATOM 280 CA BGLY 36 8.681 53.929 -5.633 0.33 58.67 C Unresolved disorder model. using A ATOM 281 C AGLY 36 7.110 53.355 -5.909 0.67 63.69 C Unresolved disorder model. using A ATOM 282 C BGLY 36 7.387 53.283 -6.091 0.33 57.81 C Unresolved disorder model. using A ATOM 283 O AGLY 36 6.877 52.979 -7.058 0.67 64.60 O Unresolved disorder model. using A ATOM 284 O BGLY 36 6.418 53.197 -5.335 0.33 58.30 O Unresolved disorder model. using A ATOM 285 N ALYS 37 6.183 53.309 -4.952 0.67 63.69 N Unresolved disorder model. using A ATOM 286 N BLYS 37 7.384 52.827 -7.342 0.33 56.77 N Unresolved disorder model. using A ATOM 287 CA ALYS 37 4.826 52.818 -5.238 0.67 62.80 C Unresolved disorder model. using A ATOM 288 CA BLYS 37 6.213 52.208 -7.957 0.33 54.74 C Unresolved disorder model. using A ATOM 289 C ALYS 37 4.033 53.909 -5.967 0.67 61.94 C Unresolved disorder model. using A ATOM 290 C BLYS 37 5.107 53.243 -8.085 0.33 53.51 C Unresolved disorder model. using A ATOM 291 O ALYS 37 4.629 54.807 -6.572 0.67 63.40 O Unresolved disorder model. using A ATOM 292 O BLYS 37 3.986 52.928 -8.486 0.33 53.62 O Unresolved disorder model. using A ATOM 293 CB ALYS 37 4.103 52.447 -3.939 0.67 63.42 C Unresolved disorder model. using A ATOM 294 CB BLYS 37 5.719 51.017 -7.131 0.33 54.49 C Unresolved disorder model. using A ATOM 295 CG ALYS 37 4.745 51.309 -3.163 0.67 64.74 C Unresolved disorder model. using A ATOM 296 CG BLYS 37 6.426 49.709 -7.443 0.33 54.29 C Unresolved disorder model. using A ATOM 297 CD ALYS 37 4.629 49.989 -3.904 0.67 65.93 C Unresolved disorder model. using A ATOM 298 CD BLYS 37 5.690 48.532 -6.819 0.33 54.90 C Unresolved disorder model. using A ATOM 299 CE ALYS 37 5.343 48.878 -3.153 0.67 66.24 C Unresolved disorder model. using A ATOM 300 CE BLYS 37 6.144 47.211 -7.422 0.33 55.07 C Unresolved disorder model. using A ATOM 301 NZ ALYS 37 5.139 47.554 -3.792 0.67 66.16 N Unresolved disorder model. using A ATOM 302 NZ BLYS 37 5.852 47.139 -8.883 0.33 54.03 N Unresolved disorder model. using A ATOM 303 N ATHR 38 2.700 53.833 -5.926 0.67 59.07 N Unresolved disorder model. using A ATOM 304 N BTHR 38 5.440 54.484 -7.746 0.33 51.81 N Unresolved disorder model. using A ATOM 305 CA ATHR 38 1.869 54.852 -6.577 0.67 56.72 C Unresolved disorder model. using A ATOM 306 CA BTHR 38 4.494 55.586 -7.810 0.33 50.44 C Unresolved disorder model. using A ATOM 307 C ATHR 38 0.890 55.467 -5.582 0.67 56.15 C Unresolved disorder model. using A ATOM 308 C BTHR 38 5.191 56.862 -8.252 0.33 48.59 C Unresolved disorder model. using A ATOM 309 O ATHR 38 0.078 56.319 -5.938 0.67 55.70 O Unresolved disorder model. using A ATOM 310 O BTHR 38 6.414 56.961 -8.207 0.33 47.16 O Unresolved disorder model. using A ATOM 311 CB ATHR 38 1.066 54.297 -7.798 0.67 55.85 C Unresolved disorder model. using A ATOM 312 CB BTHR 38 3.842 55.855 -6.430 0.33 51.87 C Unresolved disorder model. using A ATOM 313 OG1ATHR 38 -0.219 53.824 -7.376 0.67 50.29 O Unresolved disorder model. using A ATOM 314 OG1BTHR 38 4.862 56.150 -5.466 0.33 52.35 O Unresolved disorder model. using A ATOM 315 CG2ATHR 38 1.831 53.161 -8.466 0.67 56.55 C Unresolved disorder model. using A ATOM 316 CG2BTHR 38 3.043 54.641 -5.965 0.33 51.81 C Unresolved disorder model. using A ATOM 317 N ATHR 39 0.976 55.026 -4.330 0.67 55.14 N Unresolved disorder model. using A ATOM 318 N BTHR 39 4.396 57.828 -8.692 0.33 47.42 N Unresolved disorder model. using A ATOM 319 CA ATHR 39 0.120 55.544 -3.273 0.67 53.51 C Unresolved disorder model. using A ATOM 320 CA BTHR 39 4.906 59.122 -9.114 0.33 47.28 C Unresolved disorder model. using A ATOM 321 C ATHR 39 0.757 56.784 -2.648 0.67 54.58 C Unresolved disorder model. using A ATOM 322 C BTHR 39 4.256 60.112 -8.162 0.33 47.93 C Unresolved disorder model. using A ATOM 323 O ATHR 39 0.119 57.499 -1.882 0.67 53.58 O Unresolved disorder model. using A ATOM 324 O BTHR 39 4.582 61.297 -8.143 0.33 46.62 O Unresolved disorder model. using A ATOM 325 CB ATHR 39 -0.112 54.488 -2.162 0.67 51.56 C Unresolved disorder model. using A ATOM 326 CB BTHR 39 4.479 59.464 -10.552 0.33 47.09 C Unresolved disorder model. using A ATOM 327 OG1ATHR 39 1.147 53.942 -1.742 0.67 46.89 O Unresolved disorder model. using A ATOM 328 OG1BTHR 39 3.063 59.676 -10.599 0.33 45.44 O Unresolved disorder model. using A ATOM 329 CG2ATHR 39 -1.007 53.373 -2.667 0.67 49.73 C Unresolved disorder model. using A ATOM 330 CG2BTHR 39 4.850 58.334 -11.495 0.33 47.57 C Unresolved disorder model. using A ATOM 331 N AASP 40 2.015 57.042 -2.985 0.67 56.70 N Unresolved disorder model. using A ATOM 332 N BASP 40 3.335 59.584 -7.363 0.33 49.50 N Unresolved disorder model. using A ATOM 333 CA AASP 40 2.721 58.193 -2.435 0.67 59.05 C Unresolved disorder model. using A ATOM 334 CA BASP 40 2.581 60.358 -6.388 0.33 51.73 C Unresolved disorder model. using A ATOM 335 C AASP 40 3.636 58.883 -3.439 0.67 59.82 C Unresolved disorder model. using A ATOM 336 C BASP 40 3.439 61.270 -5.528 0.33 53.13 C Unresolved disorder model. using A ATOM 337 O AASP 40 4.004 58.298 -4.460 0.67 60.84 O Unresolved disorder model. using A ATOM 338 O BASP 40 3.424 62.488 -5.698 0.33 53.35 O Unresolved disorder model. using A ATOM 339 CB AASP 40 3.536 57.759 -1.219 0.67 59.90 C Unresolved disorder model. using A ATOM 340 CB BASP 40 1.793 59.420 -5.472 0.33 52.31 C Unresolved disorder model. using A ATOM 341 CG AASP 40 2.665 57.415 -0.032 0.67 62.21 C Unresolved disorder model. using A ATOM 342 CG BASP 40 0.858 58.516 -6.235 0.33 53.21 C Unresolved disorder model. using A ATOM 343 OD1AASP 40 2.223 58.348 0.677 0.67 65.18 O Unresolved disorder model. using A ATOM 344 OD1BASP 40 1.344 57.693 -7.040 0.33 54.97 O Unresolved disorder model. using A ATOM 345 OD2AASP 40 2.413 56.213 0.186 0.67 61.95 O Unresolved disorder model. using A ATOM 346 OD2BASP 40 -0.366 58.629 -6.029 0.33 53.81 O Unresolved disorder model. using A ATOM 347 N ALYS 41 3.989 60.132 -3.136 0.67 60.03 N Unresolved disorder model. using A ATOM 348 N BLYS 41 4.183 60.677 -4.599 0.33 54.84 N Unresolved disorder model. using A ATOM 349 CA ALYS 41 4.871 60.929 -3.983 0.67 59.72 C Unresolved disorder model. using A ATOM 350 CA BLYS 41 5.010 61.467 -3.707 0.33 56.47 C Unresolved disorder model. using A ATOM 351 C ALYS 41 6.311 60.461 -3.807 0.67 59.64 C Unresolved disorder model. using A ATOM 352 C BLYS 41 6.451 60.989 -3.538 0.33 57.57 C Unresolved disorder model. using A ATOM 353 O ALYS 41 6.609 59.652 -2.927 0.67 59.31 O Unresolved disorder model. using A ATOM 354 O BLYS 41 6.869 60.608 -2.443 0.33 57.77 O Unresolved disorder model. using A ATOM 355 CB ALYS 41 4.778 62.419 -3.619 0.67 61.83 C Unresolved disorder model. using A ATOM 356 CB BLYS 41 4.325 61.572 -2.340 0.33 57.45 C Unresolved disorder model. using A ATOM 357 CG ALYS 41 3.787 63.260 -4.431 0.67 64.03 C Unresolved disorder model. using A ATOM 358 CG BLYS 41 4.863 62.684 -1.450 0.33 57.70 C Unresolved disorder model. using A ATOM 359 CD ALYS 41 2.341 62.809 -4.265 0.67 66.30 C Unresolved disorder model. using A ATOM 360 CD BLYS 41 3.874 63.032 -0.345 0.33 57.58 C Unresolved disorder model. using A ATOM 361 CE ALYS 41 1.993 61.649 -5.196 0.67 67.72 C Unresolved disorder model. using A ATOM 362 CE BLYS 41 2.578 63.603 -0.918 0.33 57.47 C Unresolved disorder model. using A ATOM 363 NZ ALYS 41 0.646 61.069 -4.910 0.67 67.73 N Unresolved disorder model. using A ATOM 364 NZ BLYS 41 2.805 64.861 -1.683 0.33 56.51 N 1